Open Mobile Menu About UsManagementBoard of DirectorsCareersNewsEventsResourcesCOVID-19 ResponseContact About Us Our vision for the future We are an enzyme engineering company that applies our technology platform to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. We enable innovative sustainable processes and products, more accurate diagnostics, and better patient care – all to create a brighter future. This unified vision is what drives us to continually set high standards and raise expectations of what is possible and our impact on the world and communities around us. Creating a sustainable world Enabling sustainable processes and products is our priority towards reducing waste, pollution, and consumption. Enzymes, nature’s biocatalysts for millions of years, are significantly safer for the environment than chemicals. We engineer high-performance enzymes to meet the needs for rapid, cost-effective, and sustainable manufacturing through biocatalytic processes for pharmaceuticals, food, beverage & nutrition, and other industrial applications. Commitment to human health We are committed to improving human health through measures such as improving life science tools, enabling diagnostic innovations, and developing better biotherapeutics. We support the rare disease community by sharing professionals at worldwide conferences and hosting rare disease awareness events for staff to directly correspond with patients, clinicians, and advocacy leaders. Whether it is for novel pharmaceuticals, oral biologics, gene therapies, biosensors, or upstream research and development, our work – evolved enzymes – makes an impact on someone’s life daily. Commitment to community As a socially responsible company, Codexis strives to play a positive role by fostering a culture that promotes employee volunteering to support the communities where we operate. We participate in multiple initiatives throughout the year supporting local charitable organizations, Family Giving Tree, and Second Harvest Food Bank. To promote youth education, Codexis sponsors Future Protein Engineers, an online program encouraging innovation and creativity while having fun learning about science. 2002 Codexis Spun-Out From Maxygen 2010 Codexis IPO On Nasdaq 2012 Merck – FDA Approval For Sitagliptin API Process Using CDX-017 2014 GlaxoSmithKline – CodeEvolver® Platform License There are many steps to a healthier future. Join us on our journey. PARTNER WITH US JOIN OUR TEAM twitter linkedin CONTACTINVESTORSCAREERSTERMS OF SALETRADEMARKSPATENTSTERMS OF USEPRIVACY © 2021 Codexis. All rights reserved.